AnaptysBio, Inc. $ANAB Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lessened its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 94.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,852 shares of the biotechnology company's stock after selling 232,773 shares du...